GRACE :: Lung Cancer

Current and Emerging Approaches to Acquired Resistance for ALK/ROS1

Acquired Resistance Forum Video #9: Dr. Alice Shaw of Massachusetts General Hospital detailed for patients the so-called “next generation” ALK/ROS1 inhibitors, both those commercially available and those still in development.


Mechanisms of ALK Resistance & Implications for Treatment

Acquired Resistance Forum Video #8: Dr. Robert Doebele of the University of Colorado Cancer Center spoke to ALK and ROS1 patients about how and why their cancers become resistant to treatment and what options are available.


Questions & Answers with Drs. Blumenthal and Pennell; Moderated by Dr. West

Acquired Resistance Forum Video #7: Speakers from videos #5 and #6 at the Acquired Resistance in Lung Cancer Patient Forum sat for a moderated Q&A with Dr. Jack West.


Using Non/Off-Targeted Therapies in Targeted Lung Cancer Populations

Acquired Resistance Forum Video #6: Dr. Nate Pennell of the Cleveland Clinic discussed the other options available to patients with ALK, ROS1 and EGFR lung cancer, such as chemotherapy, Avastin, and immunotherapy.


Clinical Trial Design & Development of Highly Targeted Agents in the Molecular Era

Acquired Resistance Forum Video #5: Dr. Gideon Blumenthal of the US Food and Drug Administration (FDA) discussed the FDA process for approving targeted therapies.


Ask Us, Q&A
Lung/Thoracic Cancer Expert Content

Archives

GRACE Website Rebuild

Acquired Resistance Forum Videos

 

Watch ALK+ Lung Cancer Forum Videos

Join the GRACE Faculty

Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog

Subscribe to the GRACEcast Podcast on iTunes

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

ClinicalTrials.gov


Biomedical Learning Institute

PeerView Press - Curriculum-Based Learning Activities